BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 437918)

  • 21. Specificity of cell membrane antigens in prostatic cancer.
    Brannen GE; Gomolka DM; Coffey DS
    Cancer Chemother Rep; 1975; 59(1):127-38. PubMed ID: 1131799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system.
    Ito M; Suzuki E; Naiki M; Sendo F; Arai S
    Int J Cancer; 1984 Nov; 34(5):689-97. PubMed ID: 6209227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
    Evans R
    Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enhancement of antitumor immune responses by bleomycin].
    Morikawa K
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells.
    Hollingsworth MA; Evans DL
    J Natl Cancer Inst; 1984 Jun; 72(6):1357-63. PubMed ID: 6233443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens.
    Fritze D; Kern DH; Humme JA; Drogemuller CR; Pilch YH
    Int J Cancer; 1976 Jan; 17(1):138-47. PubMed ID: 1248898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 34. Spontaneous regression of syngeneic transplanted tumors in rats pretreated with the antileukemia drug busulfan.
    Sendo F; Miyake T; Fuyama S; Arai S
    J Natl Cancer Inst; 1978 Feb; 60(2):385-9. PubMed ID: 621755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenicity of viable tumor cells--comparison of immunogenicity between xenogenized tumor cells and BCG-tumor cell vaccine].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):908-15. PubMed ID: 4085970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.
    Suzuki Y; Suzuki K; Hosokawa M; Kobayashi H
    Cancer Immunol Immunother; 1986; 22(3):204-10. PubMed ID: 3731206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.